Chemours(US:CC) ZACKS·2025-11-07 01:01Core Insights - Chemours reported $1.5 billion in revenue for Q3 2025, a year-over-year decline of 0.4% and an EPS of $0.20, down from $0.40 a year ago, indicating a significant drop in profitability [1] - The revenue exceeded the Zacks Consensus Estimate of $1.49 billion by 0.19%, while the EPS fell short of the consensus estimate of $0.24 by 16.67% [1] Revenue Performance - Other Segment revenues were $12 million, below the average estimate of $14.67 million, reflecting a year-over-year decline of 14.3% [4] - Titanium Technologies generated $612 million, compared to the average estimate of $634.1 million, marking a year-over-year decrease of 9.9% [4] - Advanced Performance Materials reported revenues of $311 million, exceeding the average estimate of $297 million, but still down 10.6% year-over-year [4] - Thermal & Specialized Solutions achieved $560 million in revenues, slightly below the average estimate of $563.96 million, but showing a year-over-year increase of 21.7% [4] Adjusted EBITDA Analysis - Adjusted EBITDA for Titanium Technologies was $25 million, significantly lower than the average estimate of $39.7 million [4] - Corporate and Other segment reported an adjusted EBITDA of -$38 million, better than the average estimate of -$50.99 million [4] - Other Segment adjusted EBITDA was $2 million, slightly below the average estimate of $2.31 million [4] - Advanced Performance Materials had an adjusted EBITDA of $14 million, close to the average estimate of $14.9 million [4] - Thermal & Specialized Solutions reported an adjusted EBITDA of $194 million, exceeding the average estimate of $179.85 million [4] Stock Performance - Chemours shares have declined by 19.9% over the past month, contrasting with a 1.3% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), suggesting potential underperformance relative to the broader market in the near term [3]